CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase 2, Proof-of-Concept, Randomized, Double-Masked, Placebo-Controlled Study to Determine the Efficacy and Safety of LASN01 in Patients With Thyroid Eye Disease

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT06226545
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:28:15.999226+00:00
Published At: 2026-03-09T00:00:00+00:00
Record Updated At: 2026-03-09
Results Posted At: 2026-03-09
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Thyroid Eye Disease", "Graves Ophthalmopathy", "Graves Orbitopathy", "Thyroid Associated Ophthalmopathy", "Endocrine System Diseases", "Orbital Diseases", "Proptosis", "Eye Diseases"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2026-03-09"
protocolSection.identificationModule.nctId: "NCT06226545"
protocolSection.identificationModule.officialTitle: "A Phase 2, Proof-of-Concept, Randomized, Double-Masked, Placebo-Controlled Study to Determine the Efficacy and Safety of LASN01 in Patients With Thyroid Eye Disease"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2026-03-09"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.